… in non-human primates and humans are important for establishing optimal targets for
neuromodulation in the MLR. Here, we highlight recent progress … of the basal ganglia and …

… basal ganglia of naïve (normal, control) non-human primates (… beta oscillations persist during
rapid eye movement (REM) … Inpatient Sample with movement disorders between 2012 and …

… with FOG showed a disruption between the STN/GPi and cortical regions, suggesting that
FOG may be due to an overwhelming increase in the inhibitory output of the basal ganglia [39]. …

… deep brain stimulation for movement disorders. All along, there have been other great advances
… functions in the cortex of dogs and Ferrier in the nonhuman primate. Jackson required …

… of optogenetic DBS and the progress of DNA- and RNA-… in the basal ganglia of patients with
movement disorders. After … in aSyn cerebral spinal fluid (CSF) levels of non-human primates […

… deep brain stimulation (DBS) has become the neurosurgical procedure of choice for patients
in an advanced stadium of Parkinson's disease… the pathophysiology of movement disorders. …

… of deep brain stimulation (DBS) in Alzheimer’s disease (AD) … five rodent studies and two
studies with non-human primates … DBS system in epilepsy and movement disorders 66,67,68,69,…

… and the mission to advance deep brain stimulation. Financial … applications outside of
movement disorders because of our … Non-human primate studies have shown that an increase in …

… asymptomatic until progression is advanced, typically by loss … PD is primarily used to treat
PD movement disorders (MD), we … The basal ganglia output is GPi to motor thalamus to motor …

… To progress toward a more precise understanding of cognitive decline after DBS surgery,
we … DBS targets for movement disorders are within the basal ganglia, a set of nuclei linked to …